Responses
Clinical/translational cancer immunotherapy
Original research
Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter study
Compose a Response to This Article
Other responses
No responses have been published for this article.
